Pharmacist Andrew Hanna of Cornwall Takes Pharmacy to the Next Level With Launch of Patient First Virtual Care
CORNWALL, ON / ACCESSWIRE / November 27, 2020 / In an effort to help patients live happier, healthier and better...
Day: November 27, 2020
Leafbuyer Technologies, Inc. Celebrates Annual “Green Friday” Event
Leafbuyer Turns Black Friday Green with Cannabis Deals Event DENVER, CO / ACCESSWIRE / November 27, 2020 / Leafbuyer Technologies,...
Nanox Announces Revised Time of Live Demonstration at the 2020 Radiology Society of North America Virtual Annual Meeting
Live demonstration now scheduled for 11:30am EST on Thursday, December 3 Company to host investor webinar following the live demonstration...
Ceapro Inc. Reports 2020 Third Quarter and Nine-Month Financial Results and Operational Highlights
– R&D activities focused on advancing the development of innovative delivery systems and yeast beta glucan as a potential inhalable...
USAN Modifies Lead Drug Candidate’s Chemical Name to ‘Simufilam’
Future References to Lead Drug Candidate for Alzheimer’s Disease Will Be Simufilam AUSTIN, Texas, Nov. 27, 2020 (GLOBE NEWSWIRE) --...
CEO Dr. Shankar Musunuri to be Featured as a Panelist at Xconomy’s Xcelerating Life Sciences Virtual Event Discussing The Promise of Cell & Gene Therapies
MALVERN, Pa., Nov. 27, 2020 (GLOBE NEWSWIRE) -- Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and...
DARPA and JPEO Award Contract to SmartPharm, a Subsidiary of Sorrento, for Development of Rapid Countermeasure Against COVID-19 Using Gene-Encoded Neutralizing Antibodies
Initial funding of up to $34 million for the project “Gene Mabs: A Scalable, Economic, Gene-Encoded Protective Antibody Platform Against...
Phathom Pharmaceuticals to Participate at Upcoming Investor Healthcare Conferences
FLORHAM PARK, N.J., Nov. 27, 2020 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a late clinical-stage biopharmaceutical company focused...
Spectral Medical to Host Virtual Investor Day on December 4, 2020
TORONTO, Nov. 27, 2020 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late stage theranostic...
Biogen and Sage Therapeutics Announce Global Collaboration to Develop and Commercialize Potential Breakthrough Therapies in Depression and Movement Disorders
Biogen and Sage enter into an agreement to jointly develop and commercialize zuranolone and SAGE-324 in the U.S. Biogen to...
Rhythm Pharmaceuticals Announces FDA Approval of IMCIVREE™ (setmelanotide) as First-ever Therapy for Chronic Weight Management in Patients with Obesity Due to POMC, PCSK1 or LEPR Deficiency
IMCIVREE™(setmelanotide) Logo Rhythm Pharmaceuticals Announces FDA Approval of IMCIVREE™(setmelanotide) as First-ever Therapy for Chronic Weight Management in Patients with Obesity...
Policy thought-leaders, Don Drummond and Duncan Sinclair, release long-term care report seeking to reshape the future for Canadian seniors
KINGSTON, Ontario, Nov. 27, 2020 (GLOBE NEWSWIRE) -- Today, renowned public policy experts Don Drummond and Duncan Sinclair released a...
Astellas Receives Approval of EVRENZO® (roxadustat) in Japan for the Treatment of Anemia of Chronic Kidney Disease in Adult Patients Not on Dialysis
Approval by MHLW provides new HIF-PH inhibitor treatment option for healthcare providers and adult patients with anemia of CKD not...
Nexstim Plc provides an update on the pilot study in severe depression at Kuopio University Hospital
Company announcement, Inside information, Helsinki, 27 November 2020 at 14.00 (EET) Nexstim Plc provides an update on the pilot study...
ECMOHO to Announce Third Quarter 2020 Unaudited Financial Results
SHANGHAI, China, Nov. 27, 2020 (GLOBE NEWSWIRE) -- ECMOHO Limited (Nasdaq: MOHO) (“ECMOHO” or the “Company”), a leading integrated solutions...
EXMceuticals Provides Bi-Weekly Default Status Report
VANCOUVER, British Columbia, Nov. 26, 2020 (GLOBE NEWSWIRE) -- EXMceuticals Inc. (CSE: EXM) (FSE: A2PAW2) (the “Company” or “EXM”) is...
Braingrid Limited Announces Changes to Board of Directors
TORONTO, Nov. 26, 2020 (GLOBE NEWSWIRE) -- Braingrid Limited (CSE: BGRD) (“Braingrid” or the “Company”) is pleased to announce that...
Eve & Co Announces Financial Results for the Three and Nine Months Ended September 30, 2020
STRATHROY, Ontario, Nov. 26, 2020 (GLOBE NEWSWIRE) -- Eve & Co Incorporated (the “Company” or “Eve & Co”) (TSX-V: EVE;...
Kane Biotech Announces Third Quarter 2020 Financial Results
WINNIPEG, Manitoba, Nov. 26, 2020 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), a...
Saniona AB’s Nomination Committee for the Annual General Meeting 2021
PRESS RELEASE November 26, 2020 Saniona (OMX: SANION), a clinical stage biopharmaceutical company focused on rare diseases, today announced the...